Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity - PubMed (original) (raw)

Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity

C Pourcel et al. J Virol. 1990 Feb.

Abstract

The methylation status of hepatitis B virus (HBV) DNA was investigated in different organs from two strains of transgenic mice (E36 and E11) expressing the hepatitis B surface antigen (HBsAg) gene specifically in the liver. Specific sites in the S gene were shown to be methylated in all the organs of adult mice except in the liver. These sites were methylated in 14-day-old fetal liver and were progressively demethylated during development and after birth. In one strain in which HBsAg expression is lost upon transmission by females, extensive de novo methylation of the transgene was detected in the livers and bodies of 14-day-old fetuses from transgenic females. The extent of methylation was such that activation of the gene was no longer possible. DNase I-hypersensitive sites were detected in the enhancer region of HBV in the liver of HBsAg-positive mice but not in HBsAg-negative progeny of E36 females. These data indicated that in two independent transgenic lines, HBV sequences are reproducibly activated in the developing liver along with cellular liver-specific genes and that transcription is associated with demethylation at specific sites in the S gene and with DNase hypersensitivity.

PubMed Disclaimer

Cited by

A dominant modifier of transgene methylation is mapped by QTL analysis to mouse chromosome 13.
Valenza-Schaerly P, Pickard B, Walter J, Jung M, Pourcel L, Reik W, Gauguier D, Vergnaud G, Pourcel C. Valenza-Schaerly P, et al. Genome Res. 2001 Mar;11(3):382-8. doi: 10.1101/gr.163801. Genome Res. 2001. PMID: 11230162 Free PMC article.
Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
Oka Y, Akbar SM, Horiike N, Joko K, Onji M. Oka Y, et al. Immunology. 2001 May;103(1):90-7. doi: 10.1046/j.1365-2567.2001.01202.x. Immunology. 2001. PMID: 11380696 Free PMC article.
CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.
Malanchère-Brès E, Payette PJ, Mancini M, Tiollais P, Davis HL, Michel ML. Malanchère-Brès E, et al. J Virol. 2001 Jul;75(14):6482-91. doi: 10.1128/JVI.75.14.6482-6491.2001. J Virol. 2001. PMID: 11413315 Free PMC article.
Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice.
Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SL, Butel JS. Lee TH, et al. J Virol. 1990 Dec;64(12):5939-47. doi: 10.1128/JVI.64.12.5939-5947.1990. J Virol. 1990. PMID: 2243380 Free PMC article.
Aberrant tissue specific expression of the transgene in transgenic mice that carry the hepatitis B virus genome defective in the X gene.
Nagashima H, Imai M, Iwakura Y. Nagashima H, et al. Arch Virol. 1993;132(3-4):381-97. doi: 10.1007/BF01309547. Arch Virol. 1993. PMID: 8379855

References

1. Proc Natl Acad Sci U S A. 1983 May;80(9):2534-8 - PubMed
1. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4549-53 - PubMed
1. Cell. 1986 Feb 28;44(4):535-43 - PubMed
1. Cell. 1986 Apr 11;45(1):127-36 - PubMed
1. Cell. 1986 Aug 1;46(3):409-16 - PubMed

Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity - PubMed (original) (raw)